POZEN Inc. news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

POZN 8.01 +0.19 (2.43%)
price chart
Stock Analysis on POZEN Inc (NASDAQ:POZN)
POZEN Inc (NASDAQ:POZN) is currently trading 15.04% below its 52-week-high, 38.42% above its 52-week-low. The 12-months range for the stock is $5.96 - $9.71.
Pozen Inc. Is A Great Opportunity For Investors (POZN)
POZEN Inc. (NASDAQ:POZN) is a fundamentally sound biotech that has FDA Decision, at the end of December, that may serve as a catalyst for a surge in share price.
Related articles »  
Why POZEN Inc. Shares Were Slammed
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Pozen Says FDA Blocked Drug Products Over Quality Lapses  Law360 (subscription)
POZEN'S PA8140/PA32540 Receives a Complete Response Letter From FDA ...  FiercePharma Manufacturing
Related articles »  
Pozen Inc. v. Par Pharmaceutical, Inc. (Fed. Cir. 2012)
Last week, in Pozen Inc. v. Par Pharmaceutical, Inc., the Federal Circuit affirmed the decision of the U.S. District Court for the Eastern District of Texas that two patents that describe treating migraines by combining two known drugs in a single dose ...
Related articles »  
What after Gilda Thomas's Insider Unload of POZEN Inc. (NASDAQ:POZN) Stock?
25,000 shares of POZEN Inc. (NASDAQ:POZN) 8.25 -0.01 -0.12% were unloaded by Gilda Thomas, the company's See Remarks. The shares are valued at about $215,300 which has been calculated on the basis of the average transactions stock price ($8.6 ...
POZEN insider Sells $215250.00 in Stock (POZN)  Dakota Financial News
Chardan Capital Markets Starts POZEN Inc. (POZN) at Buy, $10 PT
Chardan Capital Markets initiates coverage on POZEN Inc. (NASDAQ: POZN) with a Buy rating and a price target of $10.00. Analyst Keay Nakae commented, "We believe that Pozen is an intriguing small cap investment story.
POZEN Inc. Stock Downgraded (POZN)
POZEN INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago.
Related articles »  
Update: Short Interest of Pozen, Inc. Increases by 0.2%
The short interest in Pozen, Inc. (NASDAQ:POZN) has increased from 2,335,270 on March 13,2015 to 2,340,006 on March 31,2015 .
POZEN Inc. and Sanofi US Mutually Agree to Terminate US Partnership for ...
POZEN Inc. (POZN), a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it and Sanofi US have mutually agreed to terminate their agreement for commercialization of the investigational products, PA8140 ...
Sanofi and Chapel Hill's Pozen nix drug deal; Pozen shares drop  Triangle Business Journal
Related articles »  
POZEN Inc. (POZN): Pozen Inc: Huge Special Dividend And PDUFA On The ...
POZEN Inc. (NASDAQ:POZN) engages in the development of pharmaceutical products for the treatment of acute and chronic pain, and other pain-related conditions.
Related articles »